Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
<h4>Background</h4>To determine if oral metronidazole (MTZ-400 mg bid) with 2% vaginal clindamycin-cream (Clind) or a Lactobacillus acidophilus vaginal-probiotic containing oestriol (Prob) reduces 6-month bacterial vaginosis (BV) recurrence.<h4>Methods</h4>Double-blind placeb...
Guardado en:
Autores principales: | Catriona S Bradshaw, Marie Pirotta, Deborah De Guingand, Jane S Hocking, Anna N Morton, Suzanne M Garland, Glenda Fehler, Andrea Morrow, Sandra Walker, Lenka A Vodstrcil, Christopher K Fairley |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/129dfec1378a4de18c32ec55d5594e9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
por: Zhi-Luo Deng, et al.
Publicado: (2018) -
The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review
por: Larissa K. Ratten, et al.
Publicado: (2021) -
A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis
por: Erica L. Plummer, et al.
Publicado: (2021) -
Associations between vaginal pathogenic community and bacterial vaginosis in Chinese reproductive-age women.
por: Zongxin Ling, et al.
Publicado: (2013) -
Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A cross-sectional study.
por: Claire Camus, et al.
Publicado: (2021)